Incyte Corp. (INCY)
127.99
+0.18
(+0.14%)
USD |
NASDAQ |
Aug 24, 16:00
127.99
0.00 (0.00%)
After-Hours: 20:00
Incyte Shareholders Equity (Quarterly) : 6.344B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.344B |
| March 31, 2026 | 5.623B |
| December 31, 2025 | 5.167B |
| September 30, 2025 | 4.651B |
| June 30, 2025 | 4.171B |
| March 31, 2025 | 3.668B |
| December 31, 2024 | 3.448B |
| September 30, 2024 | 3.171B |
| June 30, 2024 | 2.997B |
| March 31, 2024 | 5.394B |
| December 31, 2023 | 5.190B |
| September 30, 2023 | 4.931B |
| June 30, 2023 | 4.741B |
| March 31, 2023 | 4.463B |
| December 31, 2022 | 4.370B |
| September 30, 2022 | 4.227B |
| June 30, 2022 | 4.085B |
| March 31, 2022 | 3.863B |
| December 31, 2021 | 3.770B |
| September 30, 2021 | 3.149B |
| June 30, 2021 | 2.936B |
| March 31, 2021 | 2.728B |
| December 31, 2020 | 2.611B |
| September 30, 2020 | 2.391B |
| June 30, 2020 | 2.345B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.938B |
| December 31, 2019 | 2.598B |
| September 30, 2019 | 2.423B |
| June 30, 2019 | 2.247B |
| March 31, 2019 | 2.086B |
| December 31, 2018 | 1.926B |
| September 30, 2018 | 1.803B |
| June 30, 2018 | 1.733B |
| March 31, 2018 | 1.628B |
| December 31, 2017 | 1.631B |
| September 30, 2017 | 1.758B |
| June 30, 2017 | 1.027B |
| March 31, 2017 | 965.93M |
| December 31, 2016 | 419.47M |
| September 30, 2016 | 369.99M |
| June 30, 2016 | 297.06M |
| March 31, 2016 | 227.75M |
| December 31, 2015 | 171.16M |
| September 30, 2015 | 88.74M |
| June 30, 2015 | 55.17M |
| March 31, 2015 | -41.41M |
| December 31, 2014 | -81.63M |
| September 30, 2014 | -89.59M |
| June 30, 2014 | -171.00M |
| March 31, 2014 | -162.42M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | -10.42M |
| Regeneron Pharmaceuticals, Inc. | 31.71B |
| BioMarin Pharmaceutical, Inc. | 6.322B |
| Eli Lilly & Co. | 33.88B |
| Biogen, Inc. | 18.85B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.873B |
| Total Liabilities (Quarterly) | 1.528B |
| Debt to Equity Ratio | 0.006 |
| Current Ratio | 4.593 |
| Net Debt Paydown Yield | 0.00% |